Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment.
Saved in:
| Title: | Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment. |
|---|---|
| Authors: | Baghel US; Gurukul Pharmacy College, Ranpur, 325003, Kota, India., Kriplani P; Guru Gobind Singh College of Pharmacy, Yamuna Nagar, 135001, India., Patel NM; Gurukul Pharmacy College, Ranpur, 325003, Kota, India., Kaur M; Gurukul Pharmacy College, Ranpur, 325003, Kota, India., Sharma K; Gurukul Pharmacy College, Ranpur, 325003, Kota, India., Meghani M; Gurukul Pharmacy College, Ranpur, 325003, Kota, India., Sharma A; Department of Pharmacy, University of Kota, Kota, 324005, Rajasthan, India., Singh D; E. S. I. Hospital, 324005, Kota, Rajasthan, India., Singh B; Deparment of Pure and Applied Chemistry, University of Kota, Kota, 324005, India., Setzer WN; Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT, 84043, USA.; Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL, 35899, USA., Sharifi-Rad J; Universidad Espíritu Santo, Samborondón, Ecuador. javad.sharifirad@gmail.com.; Centro de Estudios Tecnológicos, Universitarios del Golfo, Veracruz, Mexico. javad.sharifirad@gmail.com.; Department of Medicine, College of Medicine, Korea University, Seoul, 02841, Republic of Korea. javad.sharifirad@gmail.com., Calina D; Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Apr; Vol. 398 (4), pp. 3489-3511. Date of Electronic Publication: 2024 Nov 26. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
